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        Introduction 
  Integrins are formed from       and       subunits, each with a large 
extracellular domain and a single, more C-terminal transmem-
brane domain. The subunits come together in a large interface 
between the       subunit       propeller domain and the       subunit       I 
domain to form the ligand-binding head. Other domains form 
upper and lower legs in each subunit to connect the head to the 
membrane. Integrins have an overall bent conformation in the 
low affi  nity state, with the bend between the upper and lower 
legs. Upon activation, integrins extend, and a major reorienta-
tion at the interface between the       I and hybrid domains occurs 
that is linked to remodeling of the ligand-binding site in the       I 
domain (  Luo et al., 2007  ). The       I domain has three metal ion  –
  binding sites, with a Mg 
2+   ion in the central metal ion –  dependent 
adhesion site (MIDAS) fl  anked by two Ca 
2+   ions, one of which 
is in a site termed adjacent to MIDAS (ADMIDAS). Structures 
of      V     3   and      IIb     3   bound to cyclic RGD-like peptides show 
binding across the       subunit       propeller interface with the      
subunit I domain. The Asp side chain coordinates the Mg 
2+   ion 
at the       subunit I MIDAS, whereas the Arg side chain binds to 
Asp residues in the       subunit       propeller domain (  Xiong et al., 
2002; Xiao et al., 2004  ). 
  Early in hemostasis and thrombosis, the integrin      IIb     3   on 
platelets is activated and binds to its ligand fi  brinogen. Fibrino-
gen is a dumbbell-shaped molecule (  Fig. 1 a  ). Integrin      IIb     3  
binds specifi  cally to the distal ends of the dimeric fi  brinogen 
molecule in a natively unstructured region at the C terminus of 
the       subunit  (    C peptide;   Yang et al., 2001  ). The large separa-
tion between the two      IIb     3  -binding sites on fi  brinogen of    440  Å  
is well suited for cross-linking of platelets, which results in 
platelet aggregation and formation of platelet plugs in hemosta-
sis and thrombosis. In a later event in hemostasis, cleavage of 
peptides from the N termini of the fi  brinogen       and       subunits 
stimulates assembly of fi  brinogen into fi  brin. Yet later, adjacent 
fi  brinogen molecules within fi  brin are cross-linked through their 
     C peptides by the factor XIIIa transglutaminase (  Hawiger, 1995; 
Bennett, 2001  ). 
  One of the best established paradigms in integrin biology 
is the recognition of protein ligands through Arg-Gly-Asp 
(RGD) sequences, the majority of which are present within fl  ex-
ible loop regions. Eight vertebrate integrins, including      IIb     3  
and      V     3  , recognize RGD sequences in ligands, and crystal 
structures are beginning to reveal how RGD is recognized, at 
least in cyclic peptides (  Xiong et al., 2002; Xiao et al., 2004  ). 
  H
emostasis and thrombosis (blood clotting) involve 
ﬁ  brinogen binding to integrin        IIb         3   on platelets, 
resulting in platelet aggregation.        V         3   binds ﬁ  -
brinogen via an Arg-Asp-Gly (RGD) motif in ﬁ  brinogen  ’ s 
      subunit.        IIb         3   also binds to ﬁ  brinogen; however, it 
does so via an unstructured RGD-lacking C-terminal re-
gion of the       subunit (     C peptide). These distinct modes 
of ﬁ  brinogen binding enable        IIb         3   and        V         3   to function 
cooperatively in hemostasis. In this study, crystal struc-
tures reveal the integrin        IIb         3    –       C peptide interface, and, 
for comparison, integrin        IIb         3   bound to a lamprey      C 
primordial RGD motif. Compared with RGD, the GAKQA-
GDV motif in      C adopts a different backbone conﬁ  gura-
tion and binds over a more extended region. The integrin 
metal ion  –  dependent adhesion site (MIDAS) Mg 
2+   ion 
binds the      C Asp side chain. The adjacent to MIDAS 
(ADMIDAS) Ca 
2+   ion binds the      C C terminus, revealing 
a contribution for ADMIDAS in ligand binding. Structural 
data from this natively disordered      C peptide enhances 
our understanding of the involvement of      C peptide and 
integrin        IIb         3   in hemostasis and thrombosis.
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be anchored on endothelium through     V     3  ( Cheresh et al., 1989 ; 
  Smith et al., 1990  ). 
  Whether RGD and      C peptides bind to distinct or similar 
sites on      IIb     3   is controversial. Several studies show competition 
for the same binding site (  Lam et al., 1987  ;   Santoro and Lawing, 
1987; Bennett, 2001  ). Interestingly, although     C  and  RGD 
peptides were found to cross-compete, a     C  dodecapeptide 
was photo  –  cross-linked only to the      IIb   subunit,  whereas  a 
RGD hexapeptide was cross-linked to both the      IIb   and      3   subunits 
(  Santoro and Lawing, 1987  ). Binding has been described of 
RGD and      C peptides to distinct, nonoverlapping, allosterically 
linked sites (  Hu et al., 1999  ). RGD and RGD-like peptides have 
also been described to bind to distinct sites on     IIb     3  ( Cierniewski 
et al., 1999  ). Furthermore,      C peptide was reported to cross-link 
to an      IIb   site (  D  ’  Souza et al., 1990  ) that is distal from the bind-
ing site for RGD shown in crystal structures (  Xiao et al., 2004  ). 
  Because of the biological and clinical importance of the 
     C peptide in hemostasis and thrombosis, there has been great 
interest in determining its biologically relevant integrin-bound 
However, the      C region of fi  brinogen lacks an RGD motif. 
Studies on synthetic peptides show specifi  c binding of      IIb     3   to 
the      C C-terminal dodecapeptide, a gradual loss of activity 
when the dodecapeptide is truncated from its N terminus, and 
complete loss of activity when the C-terminal pentapeptide is 
removed. The minimal peptide with inhibitory activity was 
found to be the C-terminal pentapeptide, QAGDV (  Kloczewiak 
et al., 1984, 1989  ). Furthermore, removal of the     C  QAGDV 
sequence but not of two RGD sequences in fi  brinogen abolishes 
binding to      IIb     3   (  Farrell et al., 1992  ;   Holmback et al., 1996  ). 
Thus, although RGD peptides, including those corresponding to 
sequences in fi  brinogen, can inhibit binding of      IIb     3   to fi  brino-
gen, the      C peptide is the biologically important recognition 
site for      IIb     3   within fi  brinogen. In contrast to      IIb     3 ,  integrin 
     V     3   on endothelial cells binds to a distinct site containing an 
RGD motif in the fi  brinogen       subunit (  Cheresh et al., 1989  ; 
  Smith et al., 1990; Doolittle and Kollman, 2006  ). This coopera-
tive interaction between      IIb     3   and      V     3   integrins allows the 
platelet/fi  brinogen thrombus formed by activation of      IIb     3   to 
  Figure 1.       Fibrinogen and its C-terminal      subunit sequences.   (a) Ribbon diagram of ﬁ  brinogen (  Yang et al., 2001  ) with      ,      , and       subunits in green, red, 
and blue, respectively, and natively unstructured C-terminal regions of the       and       subunits (  Yang et al., 2001; Doolittle and Kollman, 2006  ) that contain 
RGD and KQAGDV sequences shown schematically as dashed lines. (b) The C-terminal sequence of the       subunit in different species. Basic and acidic res-
idues that are important for binding to ﬁ  brinogen as shown here for human and implicated for other species are shown in red. Gln and Lys residues known 
(human and lamprey;   Strong et al., 1985  ) or implicated (other species) to mediate ﬁ  brinogen cross-linking catalyzed by factor XIIIa transglutaminase are 
underlined. Sequence accession (GI) numbers of the relevant ﬁ  brinogen splice variants are 70906437, 73977998, 19527078, 61098186, 45384500, 
120145, and 120143.     793 FIBRINOGEN PEPTIDE  –  INTEGRIN        IIb         3   COMPLEX   • Springer et al. 
brinogen       subunit sequences in a diverse range of vertebrates 
(fi  brinogen is found only in vertebrates) revealed that RGD is 
found in      C in frog and lamprey (  Fig. 1 b  ). This observation, 
which, to our knowledge, is previously unremarked and there-
fore was a surprise to us, suggests an obvious evolutionary path-
way from promiscuous integrin recognition of RGD in the 
primordial jawless vertebrate the lamprey to monospecifi  c inte-
grin recognition of non-RGD sequences in most higher verte-
brates. Therefore, for comparison to human      C, we also soaked 
crystals with chimeric deca- or dodecapeptides containing the 
RGD sequence present in lamprey     C  ( Fig.  1  b ).  Structures 
were determined at 2.4  –  2.8-  Å   resolution (  Table I  ), and previous 
structures with antagonists were rerefi  ned to lower R  free   ( Table  II ). 
The structures contain the       propeller domain in the      IIb   sub-
unit; the I, hybrid, plexin-semaphorin integrin, and integrin 
EGF-like (I-EGF) domain 1 in the      3   subunit;  15  carbohydrate 
residues; and bound ligand and Fab. The structures all have an 
open headpiece (i.e., with the hybrid domain swung out) and the 
  I domain in the high affi  nity state (  Xiao et al., 2004  ) 
 The      C peptide binds at the interface between the      IIb       
propeller and      3   I domains (  Fig. 2 a  ). The binding site overlaps 
with, but is more extensive on both the       and       subunits,  than 
previously described for cyclic RGD peptides (  Xiong et al., 
2002; Xiao et al., 2004  ). The contacts on the      3   subunit  include 
not only MIDAS but also a novel water-mediated coordination 
of the      C C terminus with ADMIDAS, as described in more 
detail in the next section. The      C peptide contacts with      IIb  
lie in a groove between two long loops that connect blades 
(      sheets of the      IIb        propeller) 2 and 3 and blades 3 and 4. 
The cap subdomain of the       propeller (  Xiao et al., 2004  ) forms 
one side of this groove (  Fig. 2 b  ). In the region of the     C 
peptide N terminal to residue 404, extension along the groove 
conformation. However, in multiple crystal structures of fi  brin-
ogen and its C-terminal       subunit fragment, the     C  peptide  is 
disordered (  Pratt et al., 1997  ;   Spraggon et al., 1997  ;   Yee et al., 
1997; Yang et al., 2001  ;   Kostelansky et al., 2002  ). Crystals of 
the      C peptide fused to lysozyme or glutathione S  –  transferase 
reveal different conformations (  Donahue et al., 1994  ;   Ware 
et al., 1999  ) that are unrelated to the integrin-bound conforma-
tion described here. Nuclear magnetic resonance measurements 
of      C interaction with      IIb     3   provided  limited  information 
(  Mayo and Fan, 1996  ). In the absence of appreciation of the 
features important for specifi  c recognition of      C by      IIb     3 , 
pharmaceutical development of antithrombotics began with 
compounds with RGD or KGD motifs. Subsequent synthesis 
and screening then focused on obtaining compounds that were 
selective for      IIb     3   compared with other integrins that recognize 
RGD, such as      V     3   and      5     1   ( Scarborough  and  Gretler,  2000 ). 
Two RGD-based drugs, a small molecule, tirofi  ban, and a cyclic 
peptide, eptifi  batide, are currently used clinically to prevent 
thrombosis, and their complex structures with      IIb     3   have  been 
determined (  Xiao et al., 2004  ). 
  In this study, we investigate how the      C peptide and a re-
lated peptide containing the RGD sequence present in lamprey 
     C bind to      IIb     3  . The results reveal the biologically important 
interface between      C peptide and      IIb     3   and unexpected fea-
tures of the integrin recognition of ligands, including a direct 
role for ADMIDAS in ligand recognition. 
  Results 
  Overall complex structure 
  We soaked human      C deca- and dodecapeptides into      IIb     3  
headpiece/Fab crystals (  Xiao et al., 2004  ). Examination of fi  -
  Table I.             IIb        3        C peptide complex x-ray diffraction and reﬁ  nement data   
Peptide sequence HHLGGAKQAGDV LGGAKQAGDV HHLGGAKQRGDV LGGAKQRGDV
Space group P3  2  21 P3  2  21 P3  2  21 P3  2  21
Unit cell (a, b, c) (  Å  ) 148.3, 148.3, 176.6 148.4, 148.4, 177.2 148.5, 148.5, 176.4 148.3, 148.3,176.8
     ,      ,       (degree) 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 120
Wavelength (  Å  ) 1.07223 1.07223 1.07223 1.07223
Resolution (  Å  ) 50  –  2.5 50  –  2.8 50  –  2.6 50  –  2.4
Number of reﬂ  ections (total/unique) 557,015/77,023 362,650/55,536 416,764/68,878 609,049/87,704
Completeness (%) 99.8/100   
b   99.4/99.6   
b   98.5/87.4 99.7/99.0   
b   
I/      (I) 17.6/3.5   
b   16.2/2.8   
b   19.1/2.2   
b   17.3/2.3   
b   
R  merge   (%) 8.6/55.2b   
b   10.5/62.3   
b   8.5/43.3 9.0/56.9   
b   
Number of atoms  
       (protein/water/other)
10,538/1,043/205 10,446/557/205 10,515/1,332/205 10,537/1,142/205
R  msd   bond lengths (  Å  ) 0.006 0.006 0.007 0.007
R  msd   bond angles (degree) 1.0 1.0 1.0 1.0
R  work   (%) 14.8 15.6 14.1 14.8
R  free   (%) 19.0 20.4 19.0 19.3
Ramachandran statistics  
       (% favored/allowed/outlier)   
a   
96.9/3.0/0.1 96.5/3.4/0.1 97.1/2.6/0.2 97.1/2.7/0.2
PDB code   2VDO 2VDP 2VDQ 2VDR
R  merge   =        h          i   |I    i    (  h  )         <  I(  h  )  >  |/       h         i   I  i  (  h  ), where I  i  (  h  ) and   <  I(  h  )  >   are the ith and mean measurement of the intensity of reﬂ  ection,   h  . R  work   =        h  ||  F    obs   (  h  )|       |  F    calc   
(  h  )||/       h  |  F    obs   (  h  )|, where   F    obs   (  h  ) and   F    calc   (  h  ) are the observed and calculated structure factors, respectively. No I/      cutoff was applied. R  free   is the R value obtained 
for a test set of reﬂ  ections consisting of a randomly selected 5% subset of the data set excluded from reﬁ  nement.
 
a  Determined with RAMPAGE (  Lovell et al., 2003  ).
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complexes with the chimera peptides show how an RGD pep-
tide unconstrained by cyclization binds to an integrin and 
provide the best comparison with the     C  peptide.  The  RGD 
tripeptide adopts a highly extended conformation across the 
integrin     /     intersubunit  interface  ( Fig.  3  b ).  The  Arg  and 
Asp side chains extend in opposite directions, and the back-
bone in between is also extended. The conformation of the li-
gand backbone is stabilized as it crosses the interface between 
the      IIb   and      3   subunits by two previously unremarked water 
molecules with strong density that are held in place by hydro-
gen bonds to the side chain of      IIb   Asp-232 and backbone of 
     3   Ala-218 and that hydrogen bond to the carbonyl oxygen of 
the Arg of RGD (  Fig. 3 b  ). The Arg side chain of RGD forms 
a charged hydrogen bond to      IIb   residue  Asp-224  and  also 
forms a hydrogen bond to an      IIb   backbone carbonyl. The Asp 
side chain of RGD directly coordinates to the MIDAS Mg 
2+  
cation and is further satisfied by three hydrogen bonds to 
the      3   backbone and one to the side chain of      3   Asn-215. 
The same geometry at the Asp is seen for all      IIb     3   com-
plexes, which are in the high affi  nity state (  Fig. 3, a  –  c  ). Only 
one of the four Asp hydrogen bonds are seen at the Asp of the 
     V     3   complex (  Fig. 3 d  ) because it has a closed headpiece, 
and the two backbone nitrogens of the      1 -    1   loop have not 
moved within hydrogen bonding distance; furthermore, the side 
chain of Asn-215 should probably be fl  ipped. 
  By reducing the loss of peptide entropy upon binding, 
cyclization can increase affi  nity and is therefore widely adopted 
in drug development. Eptifi  batide is a seven-residue L peptide 
that is cyclized with a disulfi  de bond, contains homoarginine-
Gly-Asp in place of RGD, and is in clinical use for prevention 
is blocked by contact of      C residue Leu-402 with a neighbor-
ing molecule in the crystal lattice, and residues 400  –  403 have 
weak electron density and extend toward solvent. Therefore, 
we limit our structural analysis to      C octapeptide residues 
404  –  411, which show strong electron density in omit maps, in-
timately contact      IIb     3   (  Fig. 2 and Fig. 3 a  ), and have essen-
tially identical conformations in crystals soaked with    C pep tides 
400 – 411  and  402 – 411  ( Table  I ). 
  Surface representations of the binding site show not only 
the groove in which the      C peptide lies but two deeper pockets 
within this groove (  Fig. 2 b  ). The penultimate residue in the     C 
peptide, Asp-410, buries its side chain in a pocket at the MIDAS 
Mg 
2+   ion in the      3   I domain. The surface at the MIDAS Mg 
2+  
ion is not visible in this view, which is in contrast to the surface 
at the ADMIDAS Ca 
2+   ion (  Fig. 2 b  , purple), which is much 
more solvent exposed. The other deep pocket, on the      IIb   side 
of the interface, is occupied by Lys-406 of the     C  peptide 
(  Fig. 2 b  ). This is the same pocket that is occupied by the Arg 
side chain of RGD peptides. 
    Fig. 3   compares the binding modality of the     C  peptide 
(  Fig. 3 a  ) to that of RGD-like peptides (  Fig. 3, b  –  d  ). We fi  rst will 
describe the RGD peptide-binding modality and then return to 
     C and compare it with RGD. The A408R substitution yielding 
the lamprey-like RGD motif in the chimera peptide     C  ( Fig.  1  b ) 
results in retention of      IIb     3   antagonist activity (  Kloczewiak 
et al., 1989  ). In the chimera      C peptide, the Arg-408 side chain ex-
tends directly into the      IIb  -binding pocket (  Fig. 3 b  ) and displaces 
Lys-406, which binds in this pocket in the      C peptide (  Fig. 3 a  ). 
  In contrast to previous integrin structures with cyclized 
peptides (  Xiong et al., 2002; Xiao et al., 2004  ), the      IIb     3  
  Table II.       Rereﬁ  ned       IIb        3   complex x-ray diffraction and reﬁ  nement data   
  Ligand Native1 Native2 Tiroﬁ  ban Eptiﬁ  batide L-739758
Space group P3  2  21 P3  2  21 P3  2  21 P3  2  21 P3  2  21
Unit cell (a, b, c) (  Å  ) 148.9, 148.9, 176.1 148.9, 148.9, 176.4 148.6, 148.6, 177.2 149.6, 149.6, 175.7 149.2, 149.2, 176.2
     ,      ,       (degree) 90, 90, 120 90, 90,120 90, 90, 120 90, 90, 120 90, 90, 120
Wavelength (  Å  ) 0.9793 0.9793 0.9760 0.9760 0.9793
Resolution (  Å  ) 50  –  2.8 50  –  2.75 50  –  2.9 50  –  2.9 50  –  3.1
Number of reﬂ  ections  
       (total/unique)
400,460/55,875 442,121/62,512 330,745/50,662 357,439/50,647 263,308/41,586
Completeness (%) 99.9/99.8   
b   99.9/100   
b   99.7/98.2   
b   100/100   
b   99.8/99.7   
b   
I/      (I) 14.0/3.1   
b   20.0/3.0   
b   12.1/2.0   
b   14.9/2.7   
b   12.1/2.7   
b   
R  merge   (%) 13.0/68.1   
b   9.6/59.8   
b   13.9/57.8   
b   11.7/61.5   
b   14.0/55.8   
b   
Number of atoms  
       (protein/water/other)
10,404/612/210 10,461/1,129/210 10,363/355/235 10,385/364/223 10,348/98/240
R  msd   bond lengths (  Å  ) 0.005 0.006 0.005 0.005 0.007
R  msd   bond angles (degree) 0.9 1.0 0.9 0.9 1.0
R  work   (%) 16.1 14.4 16.7 16.3 18.1
R  free   (%) 20.4 19.1 20.6 21.3 22.0
Ramachandran statistics  
       (% favored/allowed/outlier)   
a   
97.3/2.5/0.2 97.2/2.5/0.3 96.5/3.3/0.2 96.8/2.9/0.2 96.5/3.3/0.2
Obsolete PDB code 1TY3 1TXV 1TY5 1TY6 1TY7
New PDB code 2VDK 2VDL 2VDM 2VDN 2VC2
R  merge   =        h          i   |I    i    (  h  )         <  I(  h  )  >  |/       h         i   I  i  (  h  ), where I  i  (  h  ) and   <  I(  h  )  >   are the ith and mean measurement of the intensity of reﬂ  ection,   h  . R  work   =        h  ||  F    obs   (  h  )|       |  F    calc   
(  h  )||/       h  |  F    obs   (  h  )|, where   F    obs   (  h  ) and   F     calc   (  h  ) are the observed and calculated structure factors, respectively. No I/      cutoff was applied. R  free   is the R value obtained 
for a test set of reﬂ  ections consisting of a randomly selected 5% subset of the data set excluded from reﬁ  nement.
 
a  Determined with RAMPAGE (  Lovell et al., 2003  ).
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Asp moiety of      C has a conformation identical to that of 
Arg-Gly-Asp, and the carbonyl oxygen of Ala-408 hydrogen 
bonds to the two water molecules held in place by      IIb  Asp-232 
at the interface with the      3   subunit in a geometry identical to 
that seen for the Arg and homoarginine carbonyl oxygens of 
RGD and eptifi  batide (  Fig. 3, a  –  c  ). Indeed, the C      atoms of 
Ala-408 of      C and the Arg of RGD occupy identical posi-
tions (  Fig. 3, a and b  ). The critical difference between the     C 
peptide –   and RGD peptide  –  binding modalities is the back-
bone turn at      C residue Gln-407, which orients the N-terminal 
portion of the      C peptide into the groove formed by the long 
loops that connect      IIb        propeller blades 2 and 3 and blades 
3 and 4 (  Fig. 3 a  ). The backbone turn at      C Gln-407 enables the 
     C Lys-406 side chain to enter the      IIb   binding pocket from a 
markedly different location than the Arg side chain of RGD 
(  Fig. 3, a and b  ). The last few atoms of the Lys-406 side chain 
turn to approach      IIb   Asp-224 from a similar direction as 
Arg (  Fig. 3, a and b  ). A 15-fold loss of potency upon substitu-
tion of Lys-406 with Arg (  Kloczewiak et al., 1989  ) is explica-
ble by the inability of the planar guanido group of Arg to 
similarly turn. Hydrophobic      IIb   residues Tyr-190, Leu-192, 
and Phe-231 line the pocket and contact the aliphatic portion 
of the      C Lys-406 side chain and the Ala-408 side chain. 
of thrombosis (  Fig. 3 c  ). Eptifi  batide binds similarly to RGD, 
and the carbonyl oxygen of its homoarginine residue similarly 
hydrogen bonds to the waters held in place by     IIb  Asp-232 ( Fig. 3 c ). 
However, cyclization pins back the homoarginine C      and  N 
atoms so that the C      atom of homoarginine is in a similar position 
to the C      atom of Arg, explaining the requirement for the one-
carbon longer homoarginine side chain (  Fig. 3, b and c  ). 
  Cilengetide, an      V     3   antagonist, is a fi  ve-residue peptide 
that contains RGD,   N  -methyl-Val, and   d  -Phe (  Fig. 3 d  ). The Arg 
of cilengitide forms a charged hydrogen bond to      V   residue 
Asp-218. Cilengetide is cyclized through its peptide backbone 
in a considerably smaller ring than epitifi  batide. Tight cycliza-
tion, which is important to prevent binding to     IIb     3  ( Scarborough 
and Gretler, 2000; Gottschalk and Kessler, 2002  ), pulls the Arg 
backbone back away from the      V   subunit and helps place the 
Arg side chain further above the subunit than the Arg or homo-
arginine of      IIb   ligands, as appropriate for the shallower      V   bind-
ing pocket (  Fig. 3 d  ). 
 The  fi  brinogen      C peptide complex with      IIb     3   reveals 
that      C residue Lys-406 forms a charged hydrogen bond to 
     IIb   residue  Asp-224  ( Fig.  3  a ).  Therefore,     C  Lys-406  is 
functionally equivalent to the Arg of RGD (  Fig. 3 b  ) and the 
homoarginine of eptifi  batide (  Fig. 3 c  ). Furthermore, the Ala-Gly-
  Figure 2.       The binding pocket for the     C peptide.   
(a) Overview. (b) Detail.        IIb         3   and 10E5 Fab are shown 
as solvent-accessible surfaces, with the      C peptide 
shown in spheres (a) or sticks (b). Lys-406 and Asp-
410 are the most buried residues. The surface at the 
ADMIDAS metal is colored purple (as is that at the 
MIDAS, which is not visible), and the water coordi-
nating the Val-411      -carboxyl to the ADMIDAS is a 
red sphere. Figures were made with Pymol (DeLano 
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     C residues Gly-404, Ala-405, and Lys-406 fi  ll the groove be-
tween adjacent       propeller blades and form backbone  –  back-
bone and backbone – side chain hydrogen bonds to      IIb  residues 
Asp-159 and Ser-226 (  Fig. 3 a  ).      C residues Gly-404 and Ala-
405 also seal the binding pocket for the Lys-406 side chain, 
with      C residue Gly-404 forming a backbone hydrogen bond 
to the      C Lys-406 side chain. 
  ADMIDAS coordination 
  An important and unexpected observation is that the free car-
boxyl group of the      C C-terminal residue Val-411 coordinates 
the      3   I domain ADMIDAS calcium ion through an intermedi-
ate water molecule with strong density (  Fig. 3 a  ). The contribu-
tion of this coordination to ligand binding is demonstrated by 
the fi  nding that amidation of the      -carboxyl group decreases by 
sixfold the potency of      C peptides in inhibiting fi  brinogen bind-
ing to      IIb     3   (  Kloczewiak et al., 1989  ). An identical ADMIDAS 
coordination is seen with the chimera QRGDV peptide (  Fig. 3 b  ). 
The signifi  cance of this observation, the notable similarity in 
backbone positions of Val-411 of the      C and chimera peptides, 
and the equivalent residue in eptifi  batide, Trp-5 (  Fig. 3, a  –  c  ), is 
discussed in the next section. 
  Discussion 
  Speciﬁ  c recognition of the ﬁ  brinogen 
    C peptide by       IIb        3   
 Our structures of    C peptides bound to     IIb     3  reveal the interface 
that is biologically important for the binding of fi  brinogen to 
activated integrin      IIb     3   on platelets. This binding event, in turn, 
leads to cross-linking of platelets by fi  brinogen and the forma-
tion of platelet plugs in hemostasis and thrombosis. Whereas 
Arg-Gly-Asp binds to eight different integrins, the fi  brinogen 
     C peptide binds only to      IIb     3 . 
 Our      C peptide complex with      IIb     3   reveals the basis for 
binding of platelet      IIb     3   and endothelial      V     3   to distinct sites in 
fi  brinogen, enabling these integrins to have complementary 
rather than competitive functions in hemostasis (  Fig. 1 a    ; 
Cheresh et al., 1989  ;   Smith et al., 1990  ). The interface on the 
integrin       subunit occupied by the      C peptide is much larger 
than that occupied by RGD.      C residues Gly-404, Ala-405, Lys-
406, and Ala-408 all interact with      IIb  . In contrast, in the linear 
RGD chimera peptide, only Arg-408 binds to the      IIb   subunit. 
This much more extensive interface with     C  enables  specifi  c 
differences between      IIb   and other integrin       subunits to be rec-
ognized as good contacts made by      IIb   and clashes made by      V . 
The shallower and narrower binding site in the      V   subunit  pre-
cludes binding of the KQAGDV moiety using the      IIb     3 -bound 
conformation. For example,      V   Ala-215  and  Asp-218  would 
both clash with KQAGDV. These results show why the     C  pep-
tide does not bind to      V . 
  In contrast, RGD does bind to      IIb     3  , and, therefore, the 
selectivity of      IIb     3   for the      C site over RGD in fibrinogen 
(  Cheresh et al., 1989  ;   Smith et al., 1990  ) must refl  ect a higher 
affi  nity for      C. Fibrinogen lacking the     C  QAGDV  pentapep-
tide fails to bind      IIb     3   and results in bleeding disorders in mice 
(  Farrell et al., 1992  ;   Holmback et al., 1996  ). This emphasizes 
  Figure 3.       Binding of the linear     C and RGD chimera peptides and com-
parison with cyclic peptides.   Ligand,       subunit, and       subunit are shown 
in green, light blue, and beige, respectively, with O, N, and S atoms in 
red, blue, and yellow, respectively. Water molecules are red spheres. Ca 
2+   
ions are gold spheres, and Mg 
2+   ions (a  –  c) or Mn 
2+   ions (d) are silver 
spheres. Fc-Fo omit maps after reﬁ  nement in the absence of ligands and the 
displayed water molecules are contoured at 3     . The complexes are        IIb         3   
(a  –  c) with      C dodecamer (a) or chimera decamer (b) peptides, disulﬁ  de-
cyclized eptiﬁ  batide peptide (c), or        V         3   with backbone-cyclized cilengitide 
peptide (d;   Xiong et al., 2002  ). One-letter code is used for residues except 
for homoarginine (Har). Residue C7 in eptiﬁ  batide (c) is amidated.     797 FIBRINOGEN PEPTIDE  –  INTEGRIN        IIb         3   COMPLEX   • Springer et al. 
     IIb  – Asp-224 than to     V  – Asp-218. The fi  nal drug developed from 
barbourin, eptifabitide, has a homoarginine side chain in place 
of lysine (  Fig. 3 c  ). This drug binds very similarly to RGD 
(  Fig. 3 b  ) and quite differently from the      C peptide, in which 
the Lys side chain enters the      IIb   binding pocket from a com-
pletely different direction (  Fig. 3 a  ). Thus, drug design starting 
from KGD ironically resulted in an RGD-like antagonist with a 
binding modality very different from KQAGDV. 
 The      C complex structure provides new insights for the 
development of second generation integrin antagonists. Mimick-
ing the novel route into the      IIb   binding pocket adopted by the 
Lys of the KQAGDV motif should enable development of new 
classes of highly specifi  c      IIb     3   antithrombotics. Furthermore, 
mimicking the novel interaction with the ADMIDAS metal 
ion is attractive for improving the specifi  city and affi  nity of 
antagonists to a wide range of integrins. 
 The  fi  nding that the     C  peptide – binding  site  completely 
overlaps the RGD peptide  –  binding site defi  nitively resolves the 
long-standing controversy about whether these peptides com-
pete for binding to the same site or bind to distinct sites (  Lam 
et al., 1987  ;   Santoro and Lawing, 1987; D  ’  Souza et al., 1990  ;   Hu 
et al., 1999  ;   Bennett, 2001  ). Furthermore, our studies explain 
previous observations of photo  –  cross-linking of the     C  dodeca-
peptide peptide to only the      IIb   subunit and of an RGD hexapep-
tide to both the      IIb   and      3   subunits, with cross-competition by 
RGD and      C peptides, respectively (  Santoro and Lawing, 1987  ). 
Both peptides appeared to have the radiolabeled, photoactivat-
able reagent attached to their N-terminal    -amino groups. The ex-
clusive labeling of      IIb   by the reagent attached to     C  His-400 
is consistent with the position of Gly-404 in our structures in the 
     IIb        propeller groove and also with further extension in the 
N-terminal direction in this groove. In contrast, labeling of both 
the      IIb   and      3   subunits by the reagent attached to the residue be-
fore the Arg of RGD is consistent with the position of the corre-
sponding Gln-407 residue at the interface between the      IIb   and 
     3   subunits in the chimera deca- and dodecamer structures. 
  A role for ADMIDAS in ligand binding 
  Previous crystal structures and mutation of MIDAS-coordinating 
residues have shown that the MIDAS metal ion has a direct role 
in ligand binding (  Luo et al., 2007  ). In contrast, the ADMIDAS 
metal ion has been shown to have a regulatory role in ligand 
binding. During conversion from the low affi  nity, closed confor-
mation to the high affi  nity, open conformation of the integrin 
headpiece, remodeling of the      1 -    1   loop that coordinates to the 
ADMIDAS metal ion shifts the position of this metal ion by 3   Å   
(  Xiao et al., 2004  ). Ca 
2+   and Mn 
2+   compete for binding to 
ADMIDAS, resulting in inhibition or stimulation of ligand bind-
ing, respectively (  Chen et al., 2003  ). We note that physiologi-
cally and in the current structures, Ca 
2+   is present at ADMIDAS 
(  Xiao et al., 2004  ) and that coordination is pentagonal bi-
pyramidal, with seven oxygen ligands as typically seen for Ca 
2+ . 
ADMIDAS mutations augment ligand binding by integrins     4     7  
and      L     2   (  Chen et al., 2003, 2006  ) and, in contrast, inhibit li-
gand binding by      IIb     3   and      5     1   (  Bajt and Loftus, 1994  ;   Mould 
et al., 2003  ). In this study, we fi  nd that in addition to its regu-
latory role, ADMIDAS can also directly contribute to ligand 
the absolutely critical role of the      C peptide in recognition by 
     IIb     3  ; however, it does not mean that the      C peptide is respon-
sible for all of      IIb     3  ’ s  affi  nity for fi  brinogen. Indeed,      IIb     3   has 
100-fold higher affi  nity for fi  brinogen than for the     C  octapep-
tide (  Kloczewiak et al., 1983, 1984  ). Mutagenesis studies show 
that the binding site on the      IIb        propeller domain includes, 
but is larger than, the     C  octapeptide – binding  site  defi  ned here 
(  Kamata et al., 2001  ;   Xiao et al., 2004  ). The 10E5 Fab binds 
within this region of the      IIb        propeller that is important in fi  -
brinogen binding and blocks binding of fi  brinogen but not the 
octapeptide to      IIb     3  . Because the N terminus of the octapeptide 
extends toward the 10E5 Fab  –  binding site (  Fig. 2  ), it is tempt-
ing to speculate that regions N terminal to the     C  peptide,  in-
cluding well-folded      C module residues 144  –  392, also bind to 
     IIb     3   and, together with the      C peptide, account for the higher 
biological affi  nity of      IIb     3   for fi  brinogen than for RGD pep-
tides. Such other regions of the      C domain may also account for 
the retention of clot-retraction activity by fi  brinogen deleted 
in the QAGDV pentapeptide (  Holmback et al., 1996  ). Integrin 
binding or inhibition of clot retraction has been demonstrated us-
ing portions of      C N terminal to KQAGDV made in   Escherichia 
coli   (  Medved et al., 1997  ;   Yokoyama et al., 1999; Podolnikova 
et al., 2003  ); however;   E. coli       C fragments also express 
integrin-binding sites that are not present on native fi  brinogen 
(  Akakura et al., 2006  ). 
  Multiple crystal structures of fi  brinogen and its fragments 
show that       chain residues 404  –  411 are disordered and that resi-
dues 393  –  403, when ordered, completely differ in conformation 
from one crystal lattice to another (  Pratt et al., 1997  ;   Spraggon 
et al., 1997  ;   Yee et al., 1997; Yang et al., 2001  ;   Kostelansky et al., 
2002  ). Previous intense and creative efforts using carrier pro-
tein-driven crystallization (  Donahue et al., 1994  ;   Ware et al., 
1999  ) failed to reveal the biologically relevant conformation of 
the     C  peptide. 
  Our structures reveal the conformation that     C  residues 
404  –  411 adopt when bound to      IIb     3  . Although not inconsistent 
with the previous conclusion that QAGDV represents a minimal 
recognition unit in      C, our structure resolves the conundrum that 
QAGDV lacks a basic residue by demonstrating that Lys-406 
fulfi  lls a function similar to the Arg in RGD and that the KQAGD 
motif in      C occupies the same site as RGD. Residues Gly-404 
and Ala-405 also appear to have an important role in sealing the 
binding pocket for Lys-406 in the      IIb   groove. 
  In the absence of information on how the     C  peptide  binds 
     IIb     3  , development of the two currently approved small mole-
cule      IIb     3   therapeutics,  tirofi  ban and eptifi  batide, proceeded 
from RGD and barbourin, respectively ( Scarborough and Gretler, 
2000  ). Barbourin is a disintegrin with two highly unusual prop-
erties for a disintegrin: specifi  city for      IIb     3   and KGD in place of 
the RGD motif ( Scarborough et al., 1991 ). Lysine has a side chain 
with C    ,  C   ,  C    , and N      atoms. The Arg side chain has C    ,  C   , 
and C      atoms and a guanido group with N    ,  N    1 ,  N    2 ,  and  C    
atoms. The three N atoms of Arg give it versatility for hydrogen 
bonding. Although the Arg side chain readily forms charged hy-
drogen bonds through different guanido nitrogens to      IIb  – Asp-224 
in   Fig. 3 b   and      V    –  Asp-218 in   Fig. 3 d  , it is easy to imagine how 
a Lys in a similar position might better form a hydrogen bond to JCB • VOLUME 182 • NUMBER 4 • 2008  798
in RGD is conserved as a hydrophobic residue and suggest that 
the three-residue insertion in bony fi  shes can be accommodated as 
a longer turn between the Lys and this hydrophobic residue. 
  The presence of an RGD motif in both lamprey and frog 
and the presence of a KQ(A/V)GDX motif in warm-blooded ver-
tebrates and a KQFGG(I/L)GDI motif in bony fi  shes (  Fig. 1 b  ) 
raises the possibility that evolution from the recognition of Arg to 
Lys occurred more than once. A plausible stepping stone in this 
evolutionary process is provided by the function of Lys in fi  brin-
ogen cross-linking. In lamprey as well as in higher vertebrates, 
fi  brinogen is cross-linked within the      C peptide by the factor 
XIIIa transglutaminase (  Strong et al., 1985  ). Lys-406 is cross-
linked to Gln-398 or Gln-399 in human, and the Lys N-terminal 
to the RGD in lamprey is cross-linked to one of the more N-ter-
minal Gln residues (  Strong et al., 1985  ).   Xenopus laevis   appears 
similar to lamprey, with Lys and Gln residues N-terminal to the 
RGD. In contrast, humans, other warm-blooded vertebrates, and 
bony fi  shes resemble one another by all having the lysine that is 
known (human) or implicated (other species) in binding to      IIb     3  
as the same lysine that is known (human) or implicated (other 
species) in cross-linking. In      C peptides with RGD motifs, the 
Lys that functions in cross-linking could later have evolved a sec-
ond function in specifi  c recognition of a platelet integrin, provid-
ing an evolutionary stepping stone from RGD-based recognition 
of fi  brinogen by multiple integrins to Lys-based recognition of 
fi  brinogen by a specifi  c integrin on platelets or thrombocytes. 
Whether there is any more signifi  cance to the dual function of 
Lys-406 in human fi  brinogen       is unclear. However, there would 
be little, if any, competition between these two functions of Lys-
406 because fi  brinogen binding to platelets occurs much earlier 
in the clotting cascade than fi  brin formation, and the fi  brinogen 
that contributes to fi  brin formation is in great excess over that 
bound to platelet integrin      IIb     3 . 
  Materials and methods 
  The      C dodecapeptide was obtained from the American Peptide Co., and 
other peptides were synthesized and veriﬁ  ed by mass spectrometry by the 
biopolymer facility at the Department of Biological Chemistry and Molecular 
Pharmacology at Harvard Medical School (Boston, MA). Crystals of the        IIb         3   
headpiece bound to 10E5 Fab in 11% polyethylene glycol 3350, 0.7 M 
magnesium acetate, and 0.1 M cacodylate, pH 6.5 (  Xiao et al., 2004  ), were 
cryoprotected with a solution containing 15% polyethylene glycol 3350, 0.7 M 
magnesium acetate, and 0.1 M imidazole, pH 6.5, plus 5% step increases of 
glycerol concentration to a ﬁ  nal 20% glycerol, and then 50   μ  M of synthetic 
peptides was added in the ﬁ  nal cocktail. Crystals were soaked for 4 d at 4  °  C 
before freezing in liquid nitrogen. Diffraction data were collected with beam-
line 19ID (Advanced Photon Source) and processed with program suite 
HKL2000 (  Otwinowski and Minor, 1997  ). As there is little difference in the 
dimensions of the unit cell compared with nonpeptide-soaked crystals, the 
previously determined structure of the        IIb         3   headpiece complexed with 10E5 
Fab (1TXV; 2.7   Å  ) was directly subjected to rigid body reﬁ  nement program 
CNS (  Brunger et al., 1998  ) using the diffraction data. Electron density calcu-
lated using phases from the reﬁ  ned structure clearly showed the presence of 
the peptides. The peptide structures were built with program O and subjected 
to iterative cycles of model rebuilding in O and reﬁ  nement using CNS (version 
1.1) as previously described (  Xiao et al., 2004  ). 
  Subsequent rebuilding with Coot and reﬁ  nement  with  REFMAC5 
(  Murshudov et al., 1997  ) resulted in structures with unusually low R  free   
(  Tables I and II  ), which may be attributed to multiple factors. Regions for re-
building were identiﬁ  ed using multiple veriﬁ  cation tools in Coot to detect 
structural defects supplemented with improved deﬁ  nition of Ramachandran 
outliers, clashes, and improbable rotamers using MolProbity (  Davis et al., 
2007  ). Rebuilding ﬁ  rst focused on the higher resolution 2.4- and 2.6-  Å        C 
binding. The      C C-terminal COOH group coordinates the 
ADMIDAS Ca 
2+   ion through water with strong electron density. 
The importance of this interaction is demonstrated by the sixfold 
loss in inhibitory potency of      C peptides when the C terminus 
is amidated. 
  It should be noted that the amidation experiment only dem-
onstrates that coordination to a charged carboxyl oxygen is stron-
ger than to a carbonyl oxygen. Both types of oxygens form direct 
and indirect water-mediated coordinations to Ca 
2+   ( Harding, 
2001  ). Therefore, the importance of ADMIDAS coordination 
may extend beyond fi  brinogen to include ligands with RGD se-
quences that are not followed by the C-terminal residue. In ep-
tifi  batide, the Arg-Gly-Asp-Trp-Pro-Cys sequence places a Pro 
in the same position as in the Arg-Gly-Asp-Ser-Pro sequence 
of fi  bronectin; this Pro, the bulky Trp, and cyclization place con-
straints on backbone conformation. Nonetheless, the Trp carbonyl 
oxygen in eptifi  batide is in a position very similar to that of one 
of the two      -carboxyl oxygens of the      C and chimera peptide 
Val-411 residues ( Fig. 3, a – c ). In the absence of the constraints in 
the cyclic peptide, this carbonyl could move slightly and form a 
water-mediated coordination to the ADMIDAS similarly to the 
     C and RGD chimera peptide Val-411 carboxyl group. Water 
with weak density may be in a position to make this coordination 
in the eptifi  batide complex structure (  Fig. 3 c  ). Furthermore, the 
carbonyl oxygen of the amidated Cys two residues after the Trp 
forms a water-mediated coordination to the ADMIDAS ( Fig. 3 c ). 
Water-mediated ADMIDAS coordination to RGD ligands pro-
vides a plausible explanation for the fi  nding that mutation of 
ADMIDAS-coordinating residues inhibits RGD-dependent 
binding of     5     1  to fi  bronectin ( Mould et al., 2003 ) and binding of 
     IIb     3   to the peptide GRGDSP (  Bajt and Loftus, 1994  ), although 
ADMIDAS mutations also appear to favor the inactive confor-
mation of     5     1  ( Mould et al., 2003 ). We propose that the stimula-
tory effect of ADMIDAS mutations on ligand binding by integrins 
that do not recognize RGD,      4     7   (  Chen et al., 2003  ), and      L     2  
(  Chen et al., 2006  ) refl  ects the regulatory role of ADMIDAS and 
that the inhibitory effect of ADMIDAS mutations on ligand bind-
ing by integrins that recognize RGD (or KQAGDV),      IIb     3   ( Bajt 
and Loftus, 1994  ), and      5     1   (  Mould et al., 2003  ) refl  ects a direct 
role of ADMIDAS in ligand recognition, in addition to a regula-
tory role. This proposal requires testing with further integrin  –
  ligand crystal structures. 
  Evolution of the KQAGDV motif from 
an RGD motif in ﬁ  brinogen 
 Fibrinogen fi  rst evolved in vertebrates ( Jiang and Doolittle, 2003 ). 
The signifi  cance of ADMIDAS coordination by the C-terminal 
carboxyl group of the fi  brinogen       subunit is emphasized by the 
fact that in vertebrates, the position of the C-terminal carboxyl 
group relative to the penultimate Asp residue has been invariant 
for the last 450 million years (  Fig. 1 b  ;   Strong et al., 1985  ). Thus, 
the interaction with ADMIDAS of the C-terminal carboxyl group 
fi  rst evolved in jawless vertebrates in the context of an RGD motif 
and was maintained when warm-blooded vertebrates evolved the 
KQ(A/V)GD motif and bony fi  shes evolved the KQFGG(I/L)GD 
motif in place of the RGD motif (  Fig. 1 b  ). Our structures also ex-
plain why in fi  brinogen the residue that takes the place of the Arg 799 FIBRINOGEN PEPTIDE  –  INTEGRIN        IIb         3   COMPLEX   • Springer et al. 
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calcium-binding site.       Biochemistry   .    41 : 12124  –  12132 .    
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chimera deca- and dodecapeptide structures. These structures were reﬁ  ned 
in parallel so that rebuilding could focus on problems identiﬁ  ed by veriﬁ  ca-
tion tools or discrepancies between the model and electron density that 
were shared between two independent datasets. One of the shared discrep-
ancies was a clash at        IIb   residue 282 accompanied by a lack of density for 
the putative Ala-282 C      atom; checking of the nucleotide sequence used for 
       IIb   expression and RefSeq entry gi88758615 reveals Gly at this position 
compared with Ala in UniProt entry P08514. Rebuilding of the Fab was 
aided by comparison with multiple high resolution V  H  , C  HI  , V  L  , and C  L   do-
mains that were found by BlastP search of the protein database and were 
individually superimposed on the 10E5 Fab. In the four      C and chimera      C 
peptide complexes, Fab residue Asn-157 in the light chain appears to have 
largely undergone deamidation with conversion to isoaspartic acid. This resi-
due is in an Asn-Gly sequence, the sequence known to be most susceptible 
to deamidation (  Aswad et al., 2000  ), and previous protein chemistry on the 
mouse light chain peptide containing this sequence revealed heterogeneity, 
suggesting chemical rearrangement (  Svasti and Milstein, 1972  ). The pre-
viously determined headpiece structures (  Table II  ) did not show evidence for 
isoaspartic acid, which is consistent with deamidation during prolonged 
storage of the Fab before preparation of the more recent crystals (  Table I  ). 
Although isoaspartic acid has been built in one case (  Esposito et al., 2000  ), 
we did not do so because of the difﬁ  culty of implementing the correct re-
straints for an isopeptide bond in the peptide backbone and the mixture of 
products, including    L-   and    D-  aspartic acid, that result from deamidation 
(  Aswad et al., 2000  ). The Xpleo server was used to guide rebuilding of sev-
eral loops that were difﬁ   cult to build manually (  van den Bedem et al., 
2005  ). Although not built in our previous headpiece structures (  Xiao et al., 
2004  ), I-EGF domain 1 residues 436  –  461 are clearly present, although they 
are less well ordered than other domains. The last disulﬁ  de-bonded loop of 
I-EGF1, residues 462  –  472, either was disordered or was removed by car-
boxypeptidase A, which stopped at Arg-461. Arg is known to be resistant 
to digestion by carboxypeptidase A (  Ambler, 1967  ). Compared with our 
previous headpiece structures (  Xiao et al., 2004  ), carbohydrate linkages 
were corrected to those known to occur in high mannose N-linked glycans; 
three cis-prolines were added, and one was removed. TLS reﬁ  nement in 
REFMAC5 used groups determined with the TLS Motion Determination 
server (  Painter and Merritt, 2006  ) and contributed a 2  –  3% drop in R  free  . 
  The      C dodecamer and decamer structures and the ﬁ  ve previously 
deposited        IIb         3   headpiece 10E5 Fab complex structures (  Xiao et al., 
2004  ) were then rereﬁ  ned starting with the ligands in the previous models 
and the headpiece-Fab moiety from the reﬁ  ned chimera      C decamer com-
plex 2.4-    Å     structure described in   Table I  . Ligand topology and parameter 
cif ﬁ  les were created by the PRODRG2 server (  Schuttelkopf and van Aalten, 
2004  ). The cacodylate and eptiﬁ  batide ligands are unchanged. Use of 
correct chirality and ﬂ  ip of the peptide bond relative to the thienothiophene 
moiety in the L-739758 ligand and rotations around the sulfonamide N at-
oms in L-739758 and tiroﬁ  ban result in better ﬁ  ts to density and hydrogen 
bonding to        IIb         3  . The R  free   of the ﬁ  ve previously deposited structures is de-
creased by 2.1  –  5.1%.        IIb   residue 123 appears to be a true Ramachan-
dran outlier; other outliers are in regions of poor density. All coordinates 
and structure factors have been deposited with the PDB. The unusually low 
R  free   of the deposited structures is consistent with quality assessment by the 
MolProbity server (  Davis et al., 2007  ), which returns MolProbity scores in 
the 100th percentile for all nine structures (where 100th percentile is the 
best) compared with other deposited structures at similar resolutions. 
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